May 1, 2024
REP. CLARKE AND SENATOR WELCH ISSUE STATEMENT FOLLOWING FCC WARNING NATIONWIDE IMPACT OF FINAL MONTH FOR ACP
FOR IMMEDIATE RELEASE:
May 1, 2024
MEDIA CONTACT:
e: brian.phillips@mail.house.gov
c: 202.913.0126
Washington, D.C. — Today, Congresswoman Yvette D. Clarke (NY-09)…
Read More
(REP. CLARKE AND SENATOR WELCH ISSUE STATEMENT FOLLOWING FCC WARNING NATIONWIDE IMPACT OF FINAL MONTH FOR ACP)
April 26, 2024
CLARKE ISSUES STATEMENT ON FDA DECISION TO DELAY MENTHOL BAN
FOR IMMEDIATE RELEASE:
April 26, 2024
MEDIA CONTACT:
e: brian.phillips@mail.house.gov
c: 202.913.0126
Washington, D.C. — Today, Congresswoman Yvette D. Clarke…
Read More
(CLARKE ISSUES STATEMENT ON FDA DECISION TO DELAY MENTHOL BAN)
April 24, 2024
CLARKE ISSUES STATEMENT ON THE PASSING OF CONGRESSMAN DONALD PAYNE, JR.
FOR IMMEDIATE RELEASE:
April 24, 2024
MEDIA CONTACT:
e: brian.phillips@mail.house.gov
c: 202.913.0126
Washington, D.C. — Today, Congresswoman Yvette D. Clarke…
Read More
(CLARKE ISSUES STATEMENT ON THE PASSING OF CONGRESSMAN DONALD PAYNE, JR.)
April 19, 2024
CLARKE VOTES TO CONDEMN IRANIAN ATTACK ON ISRAEL
FOR IMMEDIATE RELEASE:
April 19, 2024
MEDIA CONTACT:
e: brian.phillips@mail.house.gov
c: 202.913.0126
Washington, D.C. — Today, Congresswoman Yvette D. Clarke (NY-09)…
Read More
(CLARKE VOTES TO CONDEMN IRANIAN ATTACK ON ISRAEL)
April 18, 2024
CLARKE ISSUES STATEMENT ON VOTE AGAINST H.RES.883
FOR IMMEDIATE RELEASE:
April 18, 2024
MEDIA CONTACT:
e: brian.phillips@mail.house.gov
c: 202.913.0126
Washington, D.C. — Today, Congresswoman Yvette D. Clarke (NY-09)…
Read More
(CLARKE ISSUES STATEMENT ON VOTE AGAINST H.RES.883)
April 12, 2024
PASSING THE BIPARTISAN AFFORDABLE CONNECTIVITY PROGRAM EXTENSION ACT IS ESSENTIAL FOR AMERICA’S TRIBAL COMMUNITIES
FOR IMMEDIATE RELEASE:
April 12, 2024
MEDIA CONTACT:
e: brian.phillips@mail.house.gov
c: 202.913.0126
Washington, D.C. — Today, Congresswoman Yvette D. Clarke…
Read More
(PASSING THE BIPARTISAN AFFORDABLE CONNECTIVITY PROGRAM EXTENSION ACT IS ESSENTIAL FOR AMERICA’S TRIBAL COMMUNITIES)
